Status:
COMPLETED
Pharmacist-driven CGM Use in the Uninsured Population
Lead Sponsor:
Virginia Commonwealth University
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
This is a pilot study. The purpose is to (1) provide access to continuous glucose monitoring (CGM) to patients (purchased through a grant) and (2) systematically record and analyze the results of the ...
Eligibility Criteria
Inclusion
- adult 18 years of age or older
- diagnosis of Type 1 or Type 2 diabetes
- A1c greater than 8%
- prescribed basal insulin plus either prandial insulin or a glucagon-like peptide-1 (GLP-1) receptor agonist
Exclusion
- pregnant or breast-feeding
- on dialysis
- not appropriate for CGM use based on clinical judgment by the investigators
- patients with limited English proficiency
Key Trial Info
Start Date :
April 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03477838
Start Date
April 26 2018
End Date
December 19 2019
Last Update
February 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298